azelaic acid

(redirected from Finacea)
Also found in: Dictionary, Medical.
Related to Finacea: Azelaic acid, rosacea

azelaic acid

[¦az·ə¦lā·ik ′as·əd]
(organic chemistry)
HOOC(CH2)7CCOH Colorless leaflets; melting point 106.5°C; a dicarboxylic acid useful in lacquers, alkyd salts, organic synthesis, and formation of polyamides.
Mentioned in ?
References in periodicals archive ?
In January 2013, Glenmark informed Bayer that it had filed the ANDA and claimed that the product would not infringe the patent used for Finacea.
Pharmaceutical company Bayer HealthCare reported on Friday that it has received the US Food & Drug Administration's (FDA) approval for Finacea (azelaic acid) Foam, 15% for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.
IMS Health sales data for the 12 month period ending December 2015 reveals that the Finacea market achieved annual sales to the tune of $128.
Finacea is a topical prescription medication used to treat raised spots and pimple-like bumps of mild to moderate rosacea.
The two treatments showed equal efficacy in terms of reductions in inflammatory lesions, erythema, and physicians' global severity scores; however, only 26% of patients in the MetroGel group indicated they were bothered by stinging and burning, compared with 47% on Finacea.
Please see full Prescribing Information for FINACEA at www.
com, members can save $30 on each prescription of Finacea by registering for the program and meeting eligibility criteria.
The Food and Drug Administration has approved azelaic acid gel 15%, marketed by Berlex Laboratories as Finacea, for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea.
com is a destination site that offers the consumer an immersive experience in the Finacea brand, education and support for rosacea sufferers and actionable ideas for taking control of the condition.
Finacea, which rhymes with rosacea, is expected to be available within the first quarter of this year.
The co-promotion agreement calls for joint sales and marketing activities for FINACEA, for which Berlex received marketing approval from the U.
AzA, under the trade name Skinoren or Finacea, is marketed in about 80 countries by Intendis; its parent company, Bayer HealthCare; and their distribution partners.